{"id":180650,"date":"2026-08-17T08:13:38","date_gmt":"2026-08-17T08:13:38","guid":{"rendered":"https:\/\/pabau.com\/?p=180650"},"modified":"2026-08-17T08:13:40","modified_gmt":"2026-08-17T08:13:40","slug":"hcpcs-code-j1950","status":"publish","type":"post","link":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/","title":{"rendered":"HCPCS Code J1950: Leuprolide acetate injection billing guide"},"content":{"rendered":"\n<script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"MedicalWebPage\",\"headline\":\"HCPCS Code J1950: Leuprolide Acetate Injection Billing Guide\",\"description\":\"Billing reference for HCPCS Code J1950 (leuprolide acetate depot, per 3.75 mg). Covers dosage units, supported indications, the ICD-10 crosswalk, Medicare ASP reimbursement, prior authorization, and how J1950 differs from J9217 and J1951.\",\"url\":\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j1950\/\",\"audience\":{\"@type\":\"MedicalAudience\",\"audienceType\":\"Clinician\"},\"reviewedBy\":{\"@type\":\"Person\",\"name\":\"Dr Vanja Kitanova\",\"jobTitle\":\"Medical Reviewer\",\"affiliation\":{\"@type\":\"Organization\",\"name\":\"Pabau\"},\"knowsAbout\":[\"Medical Coding\",\"Clinical Documentation\",\"Healthcare Billing\",\"Clinical Safety\"],\"sameAs\":\"https:\/\/pabau.com\/blog\/author\/vanja\/\"},\"datePublished\":\"2026-08-07\",\"dateModified\":\"2026-08-17\"}<\/script>\n\n\n        <div id=\"key_takeaways\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/12\/Key-Takeaways-Icon.svg\" alt=\"Key takeaways\" height=\"42\" width=\"42\">\n                                <h3>Key takeaways<\/h3>\n            <\/div>\n            <div class=\"list\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>HCPCS Code J1950 covers injection of leuprolide acetate for depot suspension, per 3.75 mg, billed mainly by gynecology, oncology, and pediatric endocrinology practices.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Medicare reimburses J1950 under Part B at ASP plus 6%, with rates updated quarterly by CMS. Verify the current quarter&#8217;s payment file before you bill.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Supported indications are breast cancer, ovarian cancer, endometriosis, uterine fibroids, and central precocious puberty. Prostate cancer is not one of them.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Prostate cancer doses of leuprolide bill under J9217, and Fensolvi bills under J1951. Sending either one out on a J1950 claim invites a denial.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Only two adult strengths bill under J1950: 3.75 mg as 1 unit and 11.25 mg as 3 units. There is no 4-month or 6-month J1950 depot.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Practice management software like Pabau helps practices document medical necessity, track authorization status, and reduce J1950 denials.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<p class=\"wp-block-paragraph\">HCPCS Code J1950 is the billing code for injection of leuprolide acetate (for depot suspension), per 3.75 mg. It covers the Lupron Depot 3.75 mg and 11.25 mg strengths, plus the Lupron Depot-PED strengths used in pediatric care.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Two related products sit outside this code entirely. Eligard and the prostate cancer strengths of Lupron Depot bill under J9217, and Fensolvi (Tolmar) has its own code, J1951.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Most J1950 denials trace back to three decisions. The strength in the vial sets the code, the total milligrams set the units, and the diagnosis has to sit inside a short approved list. This guide takes them in that order.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Practices running <a href=\"https:\/\/pabau.com\/features\/claims-management-software\/\">claims management software<\/a> like Pabau&#8217;s can configure leuprolide acetate as a tracked injectable. From there you attach the required ICD-10 codes to treatment records and monitor claim status without manual cross-referencing.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/billing_codes\/hcpcs-code-j1950\/automate-claims-through-healthcode.webp\" alt=\"Automate claims and billing with Pabau\"\/><figcaption class=\"wp-element-caption\"><em>Pabau&#8217;s claims management screen sends the drug, the units, and the diagnosis straight from the treatment record, so nothing is rekeyed.<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:35px;width:800px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Field<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Code<\/td>\n<td style=\"padding:12px 16px;color:#374151\">J1950<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Long descriptor<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Injection, leuprolide acetate (for depot suspension), per 3.75 mg<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Code type<\/td>\n<td style=\"padding:12px 16px;color:#374151\">HCPCS Level II &#8211; J-code (drug injection)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Drug class<\/td>\n<td style=\"padding:12px 16px;color:#374151\">GnRH agonist \/ LHRH analog<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Products billed here<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Lupron Depot 3.75 mg and 11.25 mg; Lupron Depot-PED (AbbVie)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Products billed elsewhere<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Eligard and the prostate cancer strengths of Lupron Depot (J9217); Fensolvi (J1951)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Setting<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Outpatient \/ office-based clinical administration<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Payer program<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Medicare Part B; most commercial payers<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<h2 id=\"h-j1950-code-details-and-dosage-units\" class=\"wp-block-heading\">J1950 code details and dosage units<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">One unit of J1950 equals 3.75 mg of leuprolide acetate. Units are always the total milligrams administered divided by 3.75. Only two adult strengths and four pediatric strengths bill under this code, so any other strength on a J1950 line is a red flag.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Product and strength<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Total dose<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Units to bill<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Usual interval<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Lupron Depot 3.75 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">3.75 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">1 unit<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Every 4 weeks<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Lupron Depot 11.25 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">11.25 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">3 units<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Every 12 weeks<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Lupron Depot-PED 7.5 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">7.5 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">2 units<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Every 4 weeks<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Lupron Depot-PED 11.25 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">11.25 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">3 units<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Every 4 weeks<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Lupron Depot-PED 15 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">15 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">4 units<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Every 4 weeks<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Lupron Depot-PED 30 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">30 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">8 units<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Every 12 weeks<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Lupron Depot-PED is also supplied in an 11.25 mg three-month presentation, which bills as the same 3 units. Confirm the strength printed on the vial rather than the interval on the order, because two pediatric presentations share the 11.25 mg label.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">There is no 15 mg or 22.5 mg adult dose under J1950, and no 4-month or 6-month J1950 depot exists. Those intervals and strengths belong to J9217, which is priced per 7.5 mg.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">First Coast Service Options states the rule plainly in LCD L29215. Bill 1 unit for the 3.75 mg monthly injection, or 3 units for the 11.25 mg injection given every three months.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Always confirm the dispensed dose in the chart before calculating units. Billing 1 unit for the 11.25 mg depot is the single most common J1950 coding error.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For <a href=\"https:\/\/pabau.com\/industry\/obgyn-emr-software\/\">OB\/GYN practices<\/a> administering depot injections, building the unit calculation into the encounter template reduces this risk at the point of care. The same milligram arithmetic governs other injectable hormone codes, including <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j2320\/\">J2320<\/a>.<\/p>\n\n\n\n<h2 id=\"h-covered-indications-for-j1950\" class=\"wp-block-heading\">Covered indications for J1950<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">J1950 supports oncologic, gynecologic, and pediatric endocrine indications, and prostate cancer is not among them. First Coast Service Options publishes the reference policy in LCD L29215 and its billing and coding article A59160. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">That article lists the diagnosis codes that support payment. Other MACs publish their own equivalents, so confirm the list your contractor maintains before you bill.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Advanced breast cancer:<\/strong> Palliative hormonal treatment in pre-menopausal and peri-menopausal patients. Documentation must confirm the diagnosis and the hormone-responsive treatment intent.<\/li>\n\n\n\n<li><strong>Ovarian, fallopian tube, and primary peritoneal cancer:<\/strong> Supported through the C56.x, C57.x, and C48.x diagnosis groups. Chart notes should record the histology and the line of therapy.<\/li>\n\n\n\n<li><strong>Endometriosis:<\/strong> Management of endometriosis pain in pre-menopausal patients when surgical or hormonal alternatives have failed or are contraindicated. Documentation of prior therapy attempts is critical for approval.<\/li>\n\n\n\n<li><strong>Uterine fibroids (leiomyomata uteri):<\/strong> Pre-surgical reduction of fibroid size, typically limited to six months of therapy. Payers often limit reimbursement to the pre-operative indication specifically.<\/li>\n\n\n\n<li><strong>Central precocious puberty (CPP):<\/strong> Treatment with Lupron Depot-PED once the diagnosis is confirmed by clinical criteria and laboratory findings. Those findings typically include elevated LH and FSH with advanced bone age. The supported diagnosis code is E22.8, not the more general E30.1.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Prostate cancer (C61) belongs to the J9217 diagnosis group, not this one. CMS billing and coding article A52453 states that J1950 claims billed for prostate cancer are subject to review and possible denial. Androgen deprivation doses of leuprolide therefore bill under J9217, whatever brand the practice stocks.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Off-label uses such as gender-affirming hormone therapy are not supported under the Medicare policy for J1950. Commercial payers may hold separate positions, so verify with each plan before billing. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/pabau.com\/features\/patient-intake-software\/\">Digital intake forms<\/a> built into the clinical workflow capture the indication-specific documentation at the first visit. That beats reconstructing it during a claim dispute.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/billing_codes\/hcpcs-code-j1950\/customizable-consent-and-intake-forms.webp\" alt=\"Customizable consent and intake forms\"\/><figcaption class=\"wp-element-caption\"><em>Pabau&#8217;s intake and consent forms capture the medical necessity detail a J1950 claim needs at the first visit.<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:35px;width:800px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 id=\"h-j1950-icd-10-cm-diagnosis-code-crosswalk\" class=\"wp-block-heading\">J1950 ICD-10-CM diagnosis code crosswalk<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Every J1950 claim requires a supported ICD-10-CM diagnosis code. The table below lists the code groups that appear in the Medicare billing and coding article for each supported indication. It also shows the one code billers most often attach by mistake.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">ICD-10-CM code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Covered indication<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C50.011 &#8211; C50.929<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of breast<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Advanced hormone-responsive breast cancer<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C56.1 &#8211; C56.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of ovary<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Ovarian cancer<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C57.00 &#8211; C57.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of other and unspecified female genital organs<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Fallopian tube cancer<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C48.0 &#8211; C48.8<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of retroperitoneum and peritoneum<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Primary peritoneal cancer<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">N80.00 &#8211; N80.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Endometriosis (various sites)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Endometriosis<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">D25.0 &#8211; D25.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Leiomyoma of uterus<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Uterine fibroids<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">E22.8<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Other hyperfunction of pituitary gland<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Central precocious puberty<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C61<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of prostate<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Not supported under J1950 &#8211; bill J9217 instead<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">Always pair J1950 with the most specific ICD-10 code available. A family history or screening code will not support the claim, because the active diagnosis establishes medical necessity. Laterality and site matter on the breast codes, where an entry such as <a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c50411\/\">C50.411<\/a> replaces an unspecified one.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Some MACs list additional or more granular codes in the article attached to their LCD, so check yours before submission. For practices billing related hormone therapy codes, the <a href=\"https:\/\/pabau.com\/procedure-codes\/ivf-cpt-codes\/\">IVF CPT codes<\/a> guide covers adjacent injection coding patterns.<\/p>\n\n\n\n<h2 id=\"h-medicare-reimbursement-and-the-asp-fee-schedule-for-j1950\" class=\"wp-block-heading\">Medicare reimbursement and the ASP fee schedule for J1950<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Medicare Part B pays for J1950 using the average sales price (ASP) methodology. The payment amount is ASP plus 6%, calculated quarterly from manufacturer-reported sales data. Because leuprolide acetate pricing moves with market competition and rebate structures, the per-unit rate can shift meaningfully from one quarter to the next.<\/p>\n\n\n\n<h3 id=\"h-how-medicare-calculates-asp-plus-6\" class=\"wp-block-heading\">How Medicare calculates ASP plus 6%<\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Drug manufacturers report average sales prices to CMS quarterly, net of discounts and rebates.<\/li>\n\n\n\n<li>CMS publishes the new ASP payment rates approximately 30 days before the quarter begins.<\/li>\n\n\n\n<li>The allowed payment is ASP plus 6%, covering both the drug cost and the practice&#8217;s acquisition and handling expense.<\/li>\n\n\n\n<li>Claims are paid at the lower of the submitted charge or the ASP plus 6% rate for that quarter.<\/li>\n\n\n\n<li>The quarterly ASP Drug Pricing File is available directly from <a href=\"https:\/\/www.cms.gov\/medicare\/physician-fee-schedule\/search\/overview\" target=\"_blank\" rel=\"nofollow noopener\">CMS drug payment files<\/a>.<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">For multi-unit doses, the per-unit ASP rate is multiplied by the number of 3.75 mg units administered. An 11.25 mg depot given in a single session is billed as 3 units at the current quarter&#8217;s rate.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Always retrieve that rate from the current quarter&#8217;s file rather than relying on prior-year figures. The CMS HCPCS overview explains the full payment methodology for Level II drug codes.<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>Check the CMS ASP Drug Pricing File at the start of each quarter before submitting J1950 claims. The rate typically updates in January, April, July, and October. Submitting at a stale rate from the prior quarter creates underpayment that is difficult to recover after adjudication.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-prior-authorization-requirements-by-payer\" class=\"wp-block-heading\">Prior authorization requirements by payer<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Medicare does not currently require prior authorization for J1950 at the national level. Prior authorization is standard practice at many commercial payers, including Aetna and Blue Cross Blue Shield plans. Those plans treat GnRH analogs as specialty-tier drugs subject to medical necessity review.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Aetna:<\/strong> Requires prior authorization for leuprolide acetate under most commercial plans (CPB 0501). Documentation must confirm the supported indication, previous treatment history where required, and current clinical status.<\/li>\n\n\n\n<li><strong>Blue Cross Blue Shield plans:<\/strong> Requirements vary by regional plan. Many BCBS affiliates require authorization for GnRH agonist therapy beyond the initial course, with re-authorization every six to twelve months.<\/li>\n\n\n\n<li><strong>Medicare Advantage plans:<\/strong> Requirements differ from traditional Medicare. Always verify with the specific plan rather than the underlying Medicare policy.<\/li>\n\n\n\n<li><strong>Medicaid:<\/strong> State Medicaid programs set independent requirements. Pediatric CPP cases covered by Medicaid often require specialist attestation and laboratory documentation.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">For practices administering leuprolide acetate regularly, build an authorization tracking workflow into the practice management system. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Using <a href=\"https:\/\/pabau.com\/features\/automated-workflows-software\/\">automated workflow tools<\/a> to flag upcoming expiry dates prevents mid-treatment coverage lapses. Those lapses end in denied claims and awkward patient conversations. Record the authorization criteria for each indication in the chart before administration, not after a denial.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/billing_codes\/hcpcs-code-j1950\/automated-communication-in-pabau.webp\" alt=\"Automated communication in Pabau\"\/><figcaption class=\"wp-element-caption\"><em>Pabau&#8217;s automated reminders flag an expiring prior authorization before the next depot injection is due.<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:35px;width:800px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 id=\"h-documentation-requirements-for-a-clean-claim\" class=\"wp-block-heading\">Documentation requirements for a clean claim<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Medicare policy for leuprolide acetate, including LCD L29215 and billing and coding article A59160, requires specific clinical documentation for J1950 claims. That documentation must exist in the patient&#8217;s record at the time of the claim, not retroactively after a request for information.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Confirmed diagnosis:<\/strong> Pathology, imaging, or laboratory results establishing the supported indication. Examples include a pathology report for hormone-responsive breast or ovarian cancer, pelvic imaging for fibroids, and LH, FSH, and bone age results for CPP.<\/li>\n\n\n\n<li><strong>Indication-specific medical necessity:<\/strong> For endometriosis, documentation of failed or contraindicated alternative therapies. For the oncologic indications, the histology, hormone receptor status, and line of therapy.<\/li>\n\n\n\n<li><strong>Prescriber order:<\/strong> Signed order specifying the depot formulation, strength, and frequency. The ordered dose must match the units billed.<\/li>\n\n\n\n<li><strong>Administration record:<\/strong> Date and place of service, lot number, route of administration, and administering clinician. Medicare Part B drug audits look for all four.<\/li>\n\n\n\n<li><strong>Frequency limitations:<\/strong> MAC policies specify maximum administration intervals. Billing more frequently than the approved interval without documented clinical justification triggers automatic review.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Practices that use structured <a href=\"https:\/\/pabau.com\/features\/medical-records-management\/\">clinical records<\/a> with indication-specific fields are less likely to face documentation deficiencies during audit. Amending a chart after a claim is questioned carries compliance risk. It also rarely overturns a denial based on documentation missing at the time of service.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/billing_codes\/hcpcs-code-j1950\/comprehensive-patient-records.webp\" alt=\"Comprehensive patient records\"\/><figcaption class=\"wp-element-caption\"><em>Pabau&#8217;s patient record holds the strength dispensed, the lot number, and the diagnosis, so billed units match the chart.<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:35px;width:800px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h2 id=\"h-billing-instructions-and-claim-submission\" class=\"wp-block-heading\">Billing instructions and claim submission<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">J1950 is billed on the CMS-1500 claim form for professional billing, or on the UB-04 in an institutional outpatient setting. The fields and rules below reflect standard Medicare Part B billing for office-administered injectable drugs.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Claim field<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">What to enter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">HCPCS code<\/td>\n<td style=\"padding:12px 16px;color:#374151\">J1950<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Units<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Number of 3.75 mg units administered (1 for the 3.75 mg dose, 3 for the 11.25 mg dose)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Place of service<\/td>\n<td style=\"padding:12px 16px;color:#374151\">11 (office) or 22 (outpatient hospital), depending on where administered<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Diagnosis pointer<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Point to the primary covered-indication ICD-10 code (C50.x, C56.x, C57.x, C48.x, N80.x, D25.x, or E22.8)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Modifiers<\/td>\n<td style=\"padding:12px 16px;color:#374151\">JW if drug wastage applicable; JZ if no wastage; verify with your MAC for current guidance<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">NDC reporting<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Required by Medicaid; increasingly required by commercial payers. Include the 11-digit NDC, unit qualifier, and quantity.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">NDC reporting is mandatory for Medicaid and increasingly common for commercial payers. Each Lupron Depot and Lupron Depot-PED strength carries its own NDC. Report the number from the vial dispensed rather than a default stored in the drug library.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Drug wastage policy for the JW and JZ modifiers has changed in recent years. Verify current requirements with your <a href=\"https:\/\/www.aapc.com\/codes\/hcpcs-codes-range\/\" target=\"_blank\" rel=\"nofollow noopener\">AAPC HCPCS code reference<\/a> and your MAC&#8217;s local billing guidance. The <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j9217\/\">J9217<\/a> guide covers the same claim fields for the prostate cancer strengths.<\/p>\n\n\n\n<h2 id=\"h-common-billing-errors-and-denial-reasons\" class=\"wp-block-heading\">Common billing errors and denial reasons<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">J1950 claims fail in predictable ways, and most of those failures are preventable with a pre-submission checklist. The patterns below come from CMS billing and coding articles, MAC guidance, and payer policies such as Aetna CPB 0501.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Prostate cancer billed under J1950:<\/strong> C61 is not in this code&#8217;s diagnosis group. Androgen deprivation doses belong under J9217, and CMS article A52453 flags the J1950 version for review and possible denial.<\/li>\n\n\n\n<li><strong>A strength that does not exist under this code:<\/strong> There is no 15 mg or 22.5 mg adult J1950 dose. Those strengths are J9217 territory, and Fensolvi doses belong to J1951.<\/li>\n\n\n\n<li><strong>Unit miscalculation:<\/strong> Billing 1 unit for the 11.25 mg depot is the most frequent error. Calculate units as total milligrams administered divided by 3.75.<\/li>\n\n\n\n<li><strong>Missing or unsupported ICD-10 code:<\/strong> Submitting a diagnosis code the applicable policy does not list. A non-specific code also fails where the active diagnosis is required.<\/li>\n\n\n\n<li><strong>Frequency violations:<\/strong> Administering and billing before the approved interval has elapsed. Some MACs flag claims submitted fewer than 25 days after the prior monthly administration.<\/li>\n\n\n\n<li><strong>Prior authorization not obtained:<\/strong> Billing commercial payers without securing authorization first. Requirements change annually, so never assume last year&#8217;s approval covers the current formulary year.<\/li>\n\n\n\n<li><strong>NDC mismatch:<\/strong> Reporting the wrong NDC, or omitting it entirely on Medicaid and commercial claims. Always use the NDC from the vial dispensed.<\/li>\n\n\n\n<li><strong>Place of service error:<\/strong> Billing POS 11 when the drug was administered in an outpatient hospital setting. POS 22 applies there, and different payment rules govern.<\/li>\n\n\n\n<li><strong>Missing documentation:<\/strong> No prescriber order, no administration record, or no indication-specific medical necessity notes at the time of submission.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">In ongoing hormone therapy, one denial repeats itself unless the root cause is fixed before the next administration date. Using <a href=\"https:\/\/pabau.com\/features\/prescription-management-software\/\">prescription management software<\/a> that links the drug order to the diagnosis and the administration record catches the problem upstream of billing.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The <a href=\"https:\/\/pabau.com\/blog\/hipaa-compliance-for-medical-offices\/\">HIPAA compliance<\/a> guide for medical offices covers the record retention rules that apply to drug billing audits.<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>Build a J1950 pre-submission checklist into your billing workflow. Confirm the units billed match the strength dispensed. Check that the diagnosis code sits in the J1950 group rather than the J9217 group. Confirm authorization status for commercial claims, and read the NDC off the vial itself. A two-minute check prevents weeks of denial resolution.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-j1950-vs-related-hcpcs-codes-key-differences\" class=\"wp-block-heading\">J1950 vs related HCPCS codes: Key differences<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Leuprolide acetate is billed under more than one HCPCS code, and that is where most J1950 errors begin. The strength in the vial, not the drug name, decides which code applies. The table below shows when each code is correct.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Drug<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Drug class<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Per unit<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Primary use<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">J1950<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Leuprolide acetate depot (Lupron Depot, Lupron Depot-PED)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">GnRH agonist<\/td>\n<td style=\"padding:12px 16px;color:#374151\">3.75 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Breast and ovarian cancer, endometriosis, fibroids, CPP<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">J1951<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Leuprolide acetate (Fensolvi)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">GnRH agonist<\/td>\n<td style=\"padding:12px 16px;color:#374151\">0.25 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Central precocious puberty (6-month subcutaneous depot)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">J9217<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Leuprolide acetate depot (Lupron Depot, Eligard)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">GnRH agonist<\/td>\n<td style=\"padding:12px 16px;color:#374151\">7.5 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Advanced prostate cancer<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">J9155<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Degarelix (Firmagon)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">GnRH antagonist<\/td>\n<td style=\"padding:12px 16px;color:#374151\">1 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Advanced prostate cancer (no testosterone flare)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">J3315<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Triptorelin pamoate (Trelstar)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">GnRH agonist<\/td>\n<td style=\"padding:12px 16px;color:#374151\">3.75 mg<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Advanced prostate cancer<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<h3 id=\"h-why-prostate-cancer-doses-bill-under-j9217\" class=\"wp-block-heading\">Why prostate cancer doses bill under J9217<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">J9217 is the general leuprolide acetate depot code priced per 7.5 mg, and it is not specific to Eligard. Both Eligard and the prostate cancer strengths of Lupron Depot bill under it. Its unit math runs 7.5 mg as 1 unit, 22.5 mg as 3 units, 30 mg as 4 units, and 45 mg as 6 units.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Those strengths map to the 1-month, 3-month, 4-month, and 6-month depot intervals in that order. Note that 22.5 mg is the three-month dose under J9217, so it is not a six-month strength on any leuprolide claim. For <a href=\"https:\/\/pabau.com\/industry\/mens-health-clinic-software\/\">men&#8217;s health practices<\/a> running androgen deprivation programs, J9217 is the code the claim should carry.<\/p>\n\n\n\n<h3 id=\"h-why-fensolvi-bills-under-j1951\" class=\"wp-block-heading\">Why Fensolvi bills under J1951<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Fensolvi is a brand-name six-month subcutaneous depot from Tolmar, indicated for central precocious puberty. It is not a generic version of Lupron Depot, and it holds its own permanent code, J1951, effective July 1, 2021. J1951 is priced per 0.25 mg, so a single 45 mg dose is reported as 180 units.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Billing Fensolvi as 12 units of J1950 is a unit and product mismatch that payers catch quickly. Pediatric endocrinology practices that stock both products should keep them on separate lines in the drug library. Each line carries its own code.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">J9155 (degarelix) sits in a different drug class again. Degarelix is a GnRH antagonist rather than an agonist, and it suppresses testosterone immediately without the initial surge.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Billing J1950 when degarelix was administered, or the reverse, misrepresents the drug given and creates False Claims Act exposure. Check the descriptor against the <a href=\"https:\/\/clinicaltables.nlm.nih.gov\/apidoc\/hcpcs\/v3\/doc.html\" target=\"_blank\" rel=\"nofollow noopener\">NLM HCPCS API<\/a> before the claim goes out.<\/p>\n\n\n\n<h2 id=\"h-how-pabau-keeps-j1950-claims-clean-before-submission\" class=\"wp-block-heading\">How Pabau keeps J1950 claims clean before submission<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The J1950 checks usually live in three separate places. The strength dispensed sits in the chart, the authorization sits in a payer portal, and the unit conversion sits in the biller&#8217;s head. Nobody holds all three at the moment the injection is given, and that moment decides the claim.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pabau keeps them in one record. You can store each leuprolide product as its own billable item, with the correct code and unit conversion. The 11.25 mg dose then posts as 3 units of J1950, and a prostate cancer dose posts under J9217.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Supported diagnosis codes attach to the treatment record, and authorization dates sit on the patient file where clinical staff can see them.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The result is fewer claims that need rework. Your billers spend their time on exceptions rather than re-checking every vial, and denials stop repeating across a course of therapy.<\/p>\n\n\n        <div id=\"book_a_demo\">\n            <div class=\"left-side\">\n                <div class=\"logo\">\n                    <img decoding=\"async\"\n                        src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Logo.svg\"\n                        alt=\"Logo\"\n                        loading=\"lazy\"\n                    \/>\n                <\/div>\n\n                <h3 class=\"heading\">\n                    Reduce J1950 claim denials with Pabau                <\/h3>\n\n                <p class=\"description\">\n                    Pabau&#8217;s claims management tools help gynecology, oncology, and pediatric practices track leuprolide authorization status. Attach ICD-10 codes to patient records, and bill the right code for the strength dispensed. See how it works in your practice.                <\/p>\n\n                <div class=\"button-group\">\n                    <a href=\"\/book-demo\/\" class=\"btn btn-scale-effect btn-cta-color btn-md\">\n                        <span class=\"btn-text\">Book a demo<\/span>\n                        <div class=\"btn-icon btn-icon-right\" aria-hidden=\"true\">\n                            <svg\n                                width=\"14\"\n                                height=\"12\"\n                                viewBox=\"0 0 14 12\"\n                                fill=\"none\"\n                                xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\n                            >\n                                <path\n                                    d=\"M0.75 4.77295C0.335786 4.77295 0 5.10874 0 5.52295C0 5.93716 0.335786 6.27295 0.75 6.27295V5.52295V4.77295ZM13.2803 6.05328C13.5732 5.76039 13.5732 5.28551 13.2803 4.99262L8.50736 0.219648C8.21447 -0.073245 7.73959 -0.073245 7.4467 0.219648C7.15381 0.512542 7.15381 0.987415 7.4467 1.28031L11.6893 5.52295L7.4467 9.76559C7.15381 10.0585 7.15381 10.5334 7.4467 10.8263C7.73959 11.1191 8.21447 11.1191 8.50736 10.8263L13.2803 6.05328ZM0.75 5.52295V6.27295L12.75 6.27295V5.52295V4.77295L0.75 4.77295V5.52295Z\"\n                                    fill=\"currentColor\"\n                                ><\/path>\n                            <\/svg>\n                        <\/div>\n                    <\/a>\n                <\/div>\n            <\/div>\n\n            <div class=\"right-side\">\n                <img decoding=\"async\"\n                    src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Home-Page-Concept-4.webp\"\n                    alt=\"Pabau claims management dashboard\"\n                    loading=\"lazy\"\n                \/>\n            <\/div>\n        <\/div>\n        \n\n\n<h2 id=\"h-conclusion\" class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Most of J1950 comes down to a habit at the point of administration. Read the strength off the vial first, and the code, the units, and the diagnosis all follow from it. Practices that build that check into the injection visit stop reworking the same denial every cycle.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The trade-off worth remembering is where the work sits. Two minutes of checking before submission costs less than the weeks a denial takes to unwind. <a href=\"https:\/\/pabau.com\/book-demo\/\">Book a demo<\/a> to see how Pabau tracks authorization status and posts the right code for the strength dispensed.<\/p>\n\n\n        <div id=\"expert_picks\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/11\/Expert-Picks.svg\" alt=\"Continue your research\" height=\"42\" width=\"42\">\n                                <h3>Continue your research<\/h3>\n            <\/div>\n            <div class=\"content\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Coding an office-administered antibiotic instead?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j2010\/\">HCPCS code J2010<\/a> covers how to report the drug, the units, and the wastage modifiers.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Need the wider Medicare picture?<\/strong> <a href=\"https:\/\/pabau.com\/blog\/medicare-billing\/\">Medicare billing for practices<\/a> explains claiming channels, payment models, and the compliance rules behind them.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Billing chemotherapy drugs in the same practice?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j9267\/\">HCPCS code J9267<\/a> covers per-milligram unit reporting for an infused oncology drug.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Billing another closely reviewed injectable?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j0800\/\">HCPCS code J0800<\/a> covers corticotropin claims, where payers scrutinize medical necessity just as hard.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<h2 id=\"h-frequently-asked-questions\" class=\"wp-block-heading\">Frequently asked questions<\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1786714690057\"><h3 class=\"schema-faq-question\">What is HCPCS Code J1950 used for?<\/h3> <p class=\"schema-faq-answer\">HCPCS Code J1950 is the billing code for injection of leuprolide acetate for depot suspension, per 3.75 mg. Practices use it to bill Medicare Part B and commercial payers for administering Lupron Depot or Lupron Depot-PED. Supported indications include advanced breast cancer, ovarian cancer, endometriosis, uterine fibroids, and central precocious puberty.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786714690058\"><h3 class=\"schema-faq-question\">How many units of J1950 are billed for an 11.25 mg depot injection?<\/h3> <p class=\"schema-faq-answer\">Three units of J1950 are billed for the 11.25 mg depot dose, because each unit covers 3.75 mg. The calculation is always total mg administered divided by 3.75. Billing only 1 unit for the 11.25 mg dose is the most common J1950 coding error.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786714690059\"><h3 class=\"schema-faq-question\">What ICD-10 codes are covered with J1950?<\/h3> <p class=\"schema-faq-answer\">The supported ICD-10 groups for J1950 are C50.x for breast cancer and N80.x for endometriosis. They also include C56.x, C57.x, and C48.x for ovarian, fallopian tube, and primary peritoneal cancer. D25.x covers uterine fibroids, and E22.8 covers central precocious puberty. Verify the full list in your MAC billing and coding article, since regional policies may add more specific codes.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786714690060\"><h3 class=\"schema-faq-question\">Can you bill J1950 for prostate cancer?<\/h3> <p class=\"schema-faq-answer\">No. Prostate cancer (C61) is not in the J1950 diagnosis group. CMS billing and coding article A52453 states that such claims are subject to review and possible denial. Androgen deprivation doses of leuprolide bill under J9217, which is priced per 7.5 mg. That applies to both Eligard and the prostate cancer strengths of Lupron Depot.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786714690061\"><h3 class=\"schema-faq-question\">Which HCPCS code covers Fensolvi?<\/h3> <p class=\"schema-faq-answer\">Fensolvi bills under J1951, its own permanent code, effective July 1, 2021. J1951 is priced per 0.25 mg, so a single 45 mg subcutaneous dose is reported as 180 units. Fensolvi is a brand-name 6-month depot for central precocious puberty, not a generic version of Lupron Depot. It never bills under J1950.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786714690062\"><h3 class=\"schema-faq-question\">Does J1950 require prior authorization?<\/h3> <p class=\"schema-faq-answer\">Traditional Medicare does not require prior authorization for J1950 at the national level, but most commercial payers do. Medicare Advantage plans set their own rules, which differ from traditional Medicare. Always verify prior authorization requirements with each payer before administering leuprolide acetate.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786714690063\"><h3 class=\"schema-faq-question\">What is the Medicare reimbursement rate for J1950?<\/h3> <p class=\"schema-faq-answer\">Medicare pays for J1950 at ASP plus 6%, where the average sales price is calculated quarterly from manufacturer-reported data. The dollar amount changes every quarter, so retrieve the current rate from the CMS ASP Drug Pricing File. That file publishes roughly 30 days before each quarter begins.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786714690064\"><h3 class=\"schema-faq-question\">What is the difference between J1950 and J9155?<\/h3> <p class=\"schema-faq-answer\">J1950 covers leuprolide acetate, a GnRH agonist, while J9155 covers degarelix (Firmagon), a GnRH antagonist. Leuprolide first stimulates and then suppresses testosterone, and degarelix suppresses it immediately without a flare. Billing the wrong code misstates the drug administered, which is both a coding error and a compliance exposure.<\/p> <\/div> <div class=\"schema-faq-section\" id=\"faq-question-1786714690065\"><h3 class=\"schema-faq-question\">Is J1950 covered for endometriosis under Medicare?<\/h3> <p class=\"schema-faq-answer\">Yes. J1950 is supported for endometriosis when medical necessity is documented, including evidence that alternatives failed or are contraindicated. The claim must carry a supported ICD-10 code from the N80.x range. Coverage is generally limited to six months of therapy, and billing past that point without justification may trigger review.<\/p> <\/div> <\/div>\n","protected":false},"excerpt":{"rendered":"<p>J1950 bills leuprolide depot per 3.75 mg, so 11.25 mg is 3 units. Prostate cancer doses belong to J9217, and Fensolvi to J1951.<\/p>\n","protected":false},"author":83,"featured_media":180648,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_linkdex":"81","_yoast_wpseo_content_score":"60","_yoast_wpseo_is_cornerstone":"","_yoast_wpseo_keywordsynonyms":"[\"\",\"\",\"\",\"\"]","_yoast_wpseo_focuskw_text_input":"","_seo_original_html":"","footnotes":""},"categories":[1433,1548],"tags":[1439,3046,1582,1619,2959,1826],"class_list":["post-180650","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-billing-codes","category-hcpcs","tag-claims-management","tag-drug-billing","tag-hcpcs","tag-hcpcs-billing","tag-medicare-part-b-drugs","tag-prior-authorization"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.2 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>HCPCS Code J1950: Units, ICD-10 codes, and denials<\/title>\n<meta name=\"description\" content=\"J1950 bills leuprolide depot per 3.75 mg, so 11.25 mg is 3 units. Prostate cancer doses belong to J9217, and Fensolvi to J1951.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HCPCS Code J1950: Units, ICD-10 codes, and denials\" \/>\n<meta property=\"og:description\" content=\"J1950 bills leuprolide depot per 3.75 mg, so 11.25 mg is 3 units. Prostate cancer doses belong to J9217, and Fensolvi to J1951.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/\" \/>\n<meta property=\"og:site_name\" content=\"Pabau\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Pabau\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-17T08:13:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-17T08:13:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j1950.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Anja Dodevska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:site\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anja Dodevska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"17\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/\"},\"author\":{\"name\":\"Anja Dodevska\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#\\\/schema\\\/person\\\/f2e43b25ed02313e8781f0f4507398b9\"},\"headline\":\"HCPCS Code J1950: Leuprolide acetate injection billing guide\",\"datePublished\":\"2026-08-17T08:13:38+00:00\",\"dateModified\":\"2026-08-17T08:13:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/\"},\"wordCount\":3351,\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j1950.webp\",\"keywords\":[\"claims management\",\"Drug Billing\",\"Hcpcs\",\"Hcpcs Billing\",\"Medicare Part B Drugs\",\"Prior authorization\"],\"articleSection\":[\"Billing Codes\",\"HCPCS\"],\"inLanguage\":\"de\"},{\"@type\":[\"WebPage\",\"FAQPage\"],\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/\",\"name\":\"HCPCS Code J1950: Units, ICD-10 codes, and denials\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j1950.webp\",\"datePublished\":\"2026-08-17T08:13:38+00:00\",\"dateModified\":\"2026-08-17T08:13:40+00:00\",\"description\":\"J1950 bills leuprolide depot per 3.75 mg, so 11.25 mg is 3 units. Prostate cancer doses belong to J9217, and Fensolvi to J1951.\",\"mainEntity\":[{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690057\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690058\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690059\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690060\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690061\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690062\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690063\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690064\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690065\"}],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j1950.webp\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/hcpcs-code-j1950.webp\",\"width\":1200,\"height\":630},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/\",\"name\":\"Pabau\",\"description\":\"Clinic Software for your Business | Go Paperless Today\",\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pabau.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#organization\",\"name\":\"Pabau\",\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"width\":736,\"height\":195,\"caption\":\"Pabau\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Pabau\\\/\",\"https:\\\/\\\/x.com\\\/pabaucrm\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pabau-ltd\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pabausoftware\\\/\"],\"description\":\"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.\",\"foundingDate\":\"2011-10-20\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"201\",\"maxValue\":\"500\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#\\\/schema\\\/person\\\/f2e43b25ed02313e8781f0f4507398b9\",\"name\":\"Anja Dodevska\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg\",\"caption\":\"Anja Dodevska\"},\"description\":\"Anja Dodevska writes about healthcare, dermatology, and the day-to-day realities of running a medical practice for Pabau. She enjoys breaking down complex topics into clear, accessible content and has a soft spot for the often-overlooked aspects of clinic life. When she's not writing, she's exploring cafes, walking her dog, or spending time with friends and family.\",\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/blog\\\/author\\\/anja-dodevska\\\/\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690057\",\"position\":1,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690057\",\"name\":\"What is HCPCS Code J1950 used for?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"HCPCS Code J1950 is the billing code for injection of leuprolide acetate for depot suspension, per 3.75 mg. Practices use it to bill Medicare Part B and commercial payers for administering Lupron Depot or Lupron Depot-PED. Supported indications include advanced breast cancer, ovarian cancer, endometriosis, uterine fibroids, and central precocious puberty.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690058\",\"position\":2,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690058\",\"name\":\"How many units of J1950 are billed for an 11.25 mg depot injection?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Three units of J1950 are billed for the 11.25 mg depot dose, because each unit covers 3.75 mg. The calculation is always total mg administered divided by 3.75. Billing only 1 unit for the 11.25 mg dose is the most common J1950 coding error.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690059\",\"position\":3,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690059\",\"name\":\"What ICD-10 codes are covered with J1950?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The supported ICD-10 groups for J1950 are C50.x for breast cancer and N80.x for endometriosis. They also include C56.x, C57.x, and C48.x for ovarian, fallopian tube, and primary peritoneal cancer. D25.x covers uterine fibroids, and E22.8 covers central precocious puberty. Verify the full list in your MAC billing and coding article, since regional policies may add more specific codes.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690060\",\"position\":4,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690060\",\"name\":\"Can you bill J1950 for prostate cancer?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. Prostate cancer (C61) is not in the J1950 diagnosis group. CMS billing and coding article A52453 states that such claims are subject to review and possible denial. Androgen deprivation doses of leuprolide bill under J9217, which is priced per 7.5 mg. That applies to both Eligard and the prostate cancer strengths of Lupron Depot.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690061\",\"position\":5,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690061\",\"name\":\"Which HCPCS code covers Fensolvi?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Fensolvi bills under J1951, its own permanent code, effective July 1, 2021. J1951 is priced per 0.25 mg, so a single 45 mg subcutaneous dose is reported as 180 units. Fensolvi is a brand-name 6-month depot for central precocious puberty, not a generic version of Lupron Depot. It never bills under J1950.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690062\",\"position\":6,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690062\",\"name\":\"Does J1950 require prior authorization?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Traditional Medicare does not require prior authorization for J1950 at the national level, but most commercial payers do. Medicare Advantage plans set their own rules, which differ from traditional Medicare. Always verify prior authorization requirements with each payer before administering leuprolide acetate.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690063\",\"position\":7,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690063\",\"name\":\"What is the Medicare reimbursement rate for J1950?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Medicare pays for J1950 at ASP plus 6%, where the average sales price is calculated quarterly from manufacturer-reported data. The dollar amount changes every quarter, so retrieve the current rate from the CMS ASP Drug Pricing File. That file publishes roughly 30 days before each quarter begins.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690064\",\"position\":8,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690064\",\"name\":\"What is the difference between J1950 and J9155?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"J1950 covers leuprolide acetate, a GnRH agonist, while J9155 covers degarelix (Firmagon), a GnRH antagonist. Leuprolide first stimulates and then suppresses testosterone, and degarelix suppresses it immediately without a flare. Billing the wrong code misstates the drug administered, which is both a coding error and a compliance exposure.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690065\",\"position\":9,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/procedure-codes\\\/hcpcs-code-j1950\\\/#faq-question-1786714690065\",\"name\":\"Is J1950 covered for endometriosis under Medicare?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes. J1950 is supported for endometriosis when medical necessity is documented, including evidence that alternatives failed or are contraindicated. The claim must carry a supported ICD-10 code from the N80.x range. Coverage is generally limited to six months of therapy, and billing past that point without justification may trigger review.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"HCPCS Code J1950: Units, ICD-10 codes, and denials","description":"J1950 bills leuprolide depot per 3.75 mg, so 11.25 mg is 3 units. Prostate cancer doses belong to J9217, and Fensolvi to J1951.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/","og_locale":"de_DE","og_type":"article","og_title":"HCPCS Code J1950: Units, ICD-10 codes, and denials","og_description":"J1950 bills leuprolide depot per 3.75 mg, so 11.25 mg is 3 units. Prostate cancer doses belong to J9217, and Fensolvi to J1951.","og_url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/","og_site_name":"Pabau","article_publisher":"https:\/\/www.facebook.com\/Pabau\/","article_published_time":"2026-08-17T08:13:38+00:00","article_modified_time":"2026-08-17T08:13:40+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j1950.webp","type":"image\/webp"}],"author":"Anja Dodevska","twitter_card":"summary_large_image","twitter_creator":"@pabaucrm","twitter_site":"@pabaucrm","twitter_misc":{"Verfasst von":"Anja Dodevska","Gesch\u00e4tzte Lesezeit":"17\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#article","isPartOf":{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/"},"author":{"name":"Anja Dodevska","@id":"https:\/\/pabau.com\/de\/#\/schema\/person\/f2e43b25ed02313e8781f0f4507398b9"},"headline":"HCPCS Code J1950: Leuprolide acetate injection billing guide","datePublished":"2026-08-17T08:13:38+00:00","dateModified":"2026-08-17T08:13:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/"},"wordCount":3351,"publisher":{"@id":"https:\/\/pabau.com\/de\/#organization"},"image":{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j1950.webp","keywords":["claims management","Drug Billing","Hcpcs","Hcpcs Billing","Medicare Part B Drugs","Prior authorization"],"articleSection":["Billing Codes","HCPCS"],"inLanguage":"de"},{"@type":["WebPage","FAQPage"],"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/","url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/","name":"HCPCS Code J1950: Units, ICD-10 codes, and denials","isPartOf":{"@id":"https:\/\/pabau.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#primaryimage"},"image":{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j1950.webp","datePublished":"2026-08-17T08:13:38+00:00","dateModified":"2026-08-17T08:13:40+00:00","description":"J1950 bills leuprolide depot per 3.75 mg, so 11.25 mg is 3 units. Prostate cancer doses belong to J9217, and Fensolvi to J1951.","mainEntity":[{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690057"},{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690058"},{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690059"},{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690060"},{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690061"},{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690062"},{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690063"},{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690064"},{"@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690065"}],"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#primaryimage","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j1950.webp","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/08\/hcpcs-code-j1950.webp","width":1200,"height":630},{"@type":"WebSite","@id":"https:\/\/pabau.com\/de\/#website","url":"https:\/\/pabau.com\/de\/","name":"Pabau","description":"Clinic Software for your Business | Go Paperless Today","publisher":{"@id":"https:\/\/pabau.com\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pabau.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/pabau.com\/de\/#organization","name":"Pabau","url":"https:\/\/pabau.com\/de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/pabau.com\/de\/#\/schema\/logo\/image\/","url":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","width":736,"height":195,"caption":"Pabau"},"image":{"@id":"https:\/\/pabau.com\/de\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Pabau\/","https:\/\/x.com\/pabaucrm","https:\/\/www.linkedin.com\/company\/pabau-ltd\/","https:\/\/www.instagram.com\/pabausoftware\/"],"description":"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.","foundingDate":"2011-10-20","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"201","maxValue":"500"}},{"@type":"Person","@id":"https:\/\/pabau.com\/de\/#\/schema\/person\/f2e43b25ed02313e8781f0f4507398b9","name":"Anja Dodevska","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/06\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/06\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/06\/cropped-CE0C072E-91B7-4BB7-BD27-D1E3B38ED0CA-scaled-1-96x96.jpg","caption":"Anja Dodevska"},"description":"Anja Dodevska writes about healthcare, dermatology, and the day-to-day realities of running a medical practice for Pabau. She enjoys breaking down complex topics into clear, accessible content and has a soft spot for the often-overlooked aspects of clinic life. When she's not writing, she's exploring cafes, walking her dog, or spending time with friends and family.","url":"https:\/\/pabau.com\/de\/blog\/author\/anja-dodevska\/"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690057","position":1,"url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690057","name":"What is HCPCS Code J1950 used for?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"HCPCS Code J1950 is the billing code for injection of leuprolide acetate for depot suspension, per 3.75 mg. Practices use it to bill Medicare Part B and commercial payers for administering Lupron Depot or Lupron Depot-PED. Supported indications include advanced breast cancer, ovarian cancer, endometriosis, uterine fibroids, and central precocious puberty.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690058","position":2,"url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690058","name":"How many units of J1950 are billed for an 11.25 mg depot injection?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Three units of J1950 are billed for the 11.25 mg depot dose, because each unit covers 3.75 mg. The calculation is always total mg administered divided by 3.75. Billing only 1 unit for the 11.25 mg dose is the most common J1950 coding error.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690059","position":3,"url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690059","name":"What ICD-10 codes are covered with J1950?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The supported ICD-10 groups for J1950 are C50.x for breast cancer and N80.x for endometriosis. They also include C56.x, C57.x, and C48.x for ovarian, fallopian tube, and primary peritoneal cancer. D25.x covers uterine fibroids, and E22.8 covers central precocious puberty. Verify the full list in your MAC billing and coding article, since regional policies may add more specific codes.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690060","position":4,"url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690060","name":"Can you bill J1950 for prostate cancer?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"No. Prostate cancer (C61) is not in the J1950 diagnosis group. CMS billing and coding article A52453 states that such claims are subject to review and possible denial. Androgen deprivation doses of leuprolide bill under J9217, which is priced per 7.5 mg. That applies to both Eligard and the prostate cancer strengths of Lupron Depot.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690061","position":5,"url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690061","name":"Which HCPCS code covers Fensolvi?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Fensolvi bills under J1951, its own permanent code, effective July 1, 2021. J1951 is priced per 0.25 mg, so a single 45 mg subcutaneous dose is reported as 180 units. Fensolvi is a brand-name 6-month depot for central precocious puberty, not a generic version of Lupron Depot. It never bills under J1950.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690062","position":6,"url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690062","name":"Does J1950 require prior authorization?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Traditional Medicare does not require prior authorization for J1950 at the national level, but most commercial payers do. Medicare Advantage plans set their own rules, which differ from traditional Medicare. Always verify prior authorization requirements with each payer before administering leuprolide acetate.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690063","position":7,"url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690063","name":"What is the Medicare reimbursement rate for J1950?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Medicare pays for J1950 at ASP plus 6%, where the average sales price is calculated quarterly from manufacturer-reported data. The dollar amount changes every quarter, so retrieve the current rate from the CMS ASP Drug Pricing File. That file publishes roughly 30 days before each quarter begins.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690064","position":8,"url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690064","name":"What is the difference between J1950 and J9155?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"J1950 covers leuprolide acetate, a GnRH agonist, while J9155 covers degarelix (Firmagon), a GnRH antagonist. Leuprolide first stimulates and then suppresses testosterone, and degarelix suppresses it immediately without a flare. Billing the wrong code misstates the drug administered, which is both a coding error and a compliance exposure.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690065","position":9,"url":"https:\/\/pabau.com\/de\/procedure-codes\/hcpcs-code-j1950\/#faq-question-1786714690065","name":"Is J1950 covered for endometriosis under Medicare?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Yes. J1950 is supported for endometriosis when medical necessity is documented, including evidence that alternatives failed or are contraindicated. The claim must carry a supported ICD-10 code from the N80.x range. Coverage is generally limited to six months of therapy, and billing past that point without justification may trigger review.","inLanguage":"de"},"inLanguage":"de"}]}},"yoast":{"focus_keyword":"HCPCS Code J1950","seo_title":"HCPCS Code J1950: Units, ICD-10 codes, and denials","meta_description":"J1950 bills leuprolide depot per 3.75 mg, so 11.25 mg is 3 units. Prostate cancer doses belong to J9217, and Fensolvi to J1951.","content_score":"60","is_cornerstone":"","related_keyphrases":[{"keyword":"leuprolide acetate injection billing","score":72},{"keyword":"GnRH analog Medicare billing","score":61},{"keyword":"J1950 fee schedule 2025","score":61}]},"_links":{"self":[{"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/posts\/180650","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/users\/83"}],"replies":[{"embeddable":true,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/comments?post=180650"}],"version-history":[{"count":4,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/posts\/180650\/revisions"}],"predecessor-version":[{"id":181143,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/posts\/180650\/revisions\/181143"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/media\/180648"}],"wp:attachment":[{"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/media?parent=180650"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/categories?post=180650"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/tags?post=180650"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}